Changing roles of Western pharma in China

May 20, 2014 Tags: Business development Pharma Drug development

Senior executives from several global pharma examine how the rapidly changing landscape in China is driving their companies to adapt new research and development models to address the local market needs as well as the need for novel NMEs globally. Most pharmas have added dedicated business development teams that are seeking collaboration partners and novel assets throughout China.

Moderator: Greg B. ScottChinaBio® LLC